Issued alternative "Viagra"

The U.S. government approved the sale of new drugs early, which is expected to end the monopoly of "Viagra" in the market to combat male impotency.

The first competitor very profitable "Viagra" on the market called Levitra and is a German pharmaceutical company Bayer AG. The proliferation of new drugs is a British company GlaxoSmithKline (GSK).

Levitra is an alternative drug for the treatment of internal impotency. Unlike blue pill Viagra, Levitra painted in orange.

In 1998, the German company Pfizer began production of the drug Viagra. During this time, sales of the drug rose to 2 billion dollars a year.

Both products operate on the same principle. Doctors warned that the two drugs can have serious side effects, especially for men with heart disease.

Also this year, the United States market should have a third means of impotency Cialis.

Administration to monitor the food and medicines approved a new drug, based on the results of studies that have shown that men taking the pill Levitra, five times more likely to achieve suitable for sex abuser than those who had a placebo.

Scientists have also conducted studies of several thousand men, showed that Viagra helped more than 70% of them improved erection.

Adverse actions

Office to monitor food and drugs to the attention of scientists and about side effects in men with heart disease.

Management decided that the pill Levitra should not take people recently from heart attack or stroke, and people with too low or too high blood pressure.

The remaining men Levitra may cause side effects as headache, the temperature increase laid nose and sometimes dizziness.

"We know, thanks to a major market research that the market is ready for new options," said head of strategic management department at GSK responsible for drugs from cardiovascular disease, problems in the digestive tract and urology.

According to GSK, Levitra will appear in retail sales in the month of September.

Cheap drugs: new stops

WTO took an important step toward liberalization of patent rules. It will allow poor countries to buy and produce cheaper versions of the most effective drugs to fight serious diseases. However, after it was announced new delays in the negotiating process.

On Thursday in Geneva at the meeting of the WTO Council on Intellectual Property was approved by the compromise agreement between the United States and four developing countries. However, a few hours later learned that the WTO General Council, which has the final decision postponed resolution of the issue, citing the need for further consultations.

Until recently, the main obstacle was the position of the United States, claimed that the refusal of the patent would undermine the position of the major pharmaceutical companies working on the development of new drugs.

For many effective drugs patents are 20 years old, that prohibits copying in the form of cheaper, "vendor" forms. The very principle that developing countries could have access to cheap drugs against AIDS, malaria, tuberculosis and other serious diseases, was developed two years ago.

However, the details of its accuracy is very slow. Thus, in December, the United States blocked a draft agreement, saying it allows out under the patent laws too many drugs-for example, drugs for non-communicable diseases such as diabetes or asthma.

Now, apparently, Washington agreed to lift their objections if WTO members promise not to abuse the new rules and will be used to manufacture drugs vnepatentnomu "for higher-order" and not for commercial gain. Developing countries are also expected to take measures that will prevent a cheaper form of drugs entering the markets of rich countries. Formally, the agreement must be approved by the WTO General Council.

Will easier?

Large pharmaceutical companies welcomed the compromise. "The text of this agreement is to focus the discussion needs most disadvantaged, and this is critical," said chairman of the International Federation of Pharmaceutical Association Harvey Bailey.

Nevertheless, representatives of non-governmental organizations believe that the new document Third World country spreading a dense network of reservations and conditions, and in practice does not help the situation to treat severe disease. "The agreement will be disastrous for poor people around the world," said a major British charity Oxfam. - The text of too many bureaucratic tricks and mass constraints. "

African activists said that the United States did influence of the countries of the Third World to the signing of the agreement, which still leaves prices for medicines unacceptably high. Critically listened to the results of the Geneva meeting, representatives of India, producing many copies of drugs. "The new policy infested barriers, which will make copies of more expensive than necessary," Reuters quoted D. D. Shah, Secretary General, Indian Pharmaceutical Alliance.

Representatives of large companies explain the need for stringent patent restrictions increasing cost of research prior to creating highly drugs. According to them, pharmaceutical companies, primarily businesses, bound to balance the costs of manufacturing drugs with the proceeds of their sale.

If income for the influx of cheaper versions will go down sharply, it will be bad and shareholders, and patients are still awaiting the appearance of miracle drugs of various diseases.

The United States approved a new cancer drugs

The U.S. government has approved a drug called avastin designed to combat cancer. The principles of action-a new, it should extend the life of those who suffer colon cancer at later stages.

The product should prevent the formation of new blood vessels, thus, the tumor will not receive oxygen and other nutrients needed for growth.

The American government has approved a new drug, saying that it was the first drug that actually stops tumor growth.

Avastin is used for the treatment of patients with colon cancer at a late stage. Clinical trials showed that the drug extends the lives of seriously ill patients by an average of five months.

Designer drugs company now claims that look as avastin can be useful in dealing with other types of cancer frequently, such as breast cancer or lung.

If himoterapiya kills all fissile cells all over the body and thus lead to serious side effects, the new approach provides that the drug affects only the tumor itself.

Roche will share the secrets of medicines against avian flu

Swiss pharmaceutical company Roche will cooperate with competitors from the United States in the production of vaccine drug Tamiflu, which could help contain the spread avian influenza.
To date, Tamiflu is the most effective drug against the H5N1 virus and the government of 40 countries have filed multimillion jobs to create sufficient stocks. Roche acknowledged that for all the jobs themselves in the short term it is not in a position, despite the fact that over the last three years the annual production of the drug doubled.

But then, to convince pharmacists to open formulations for the manufacture of proprietary drugs, took effect politicians. Negotiations with the American affiliate of Roche has New York Senator Charles Schumer.

In the end, it was announced that Roche will begin negotiations with the company Teva, Barr, Mylan and Ranbaxy, with the production of generic drugs. "We will have much more Tamiflu than if Roche dealt with this self," declared Senator Schumer.

Roche "prepared to discuss"

"Roche has agreed to meet with the leadership of these companies as soon as possible, probably in early next week. It was ready to discuss the production of Tamiflu and other interested companies, "Schumer said after talks with George Abercrombie, head of the American subsidiary of Roche.

Before disclosing secrets patent, a Swiss company, however, wants to make sure that other companies in a position to produce enough drugs. "We want to make sure that they are able to produce large quantities of Tamiflu in a pandemic situation, in the time frame and with the necessary parameters."

Perhaps this explains some more cool attitude Roche regarding admission to the production companies of other countries. About their willingness to make Tamiflu said Thailand, India and Taiwan, but that the contacts Swiss pharmacists limited American companies.

World Bank cause to collaps fight with malaria

World Bank accused of fraud and waste resources on unnecessary drugs, the programme to combat malaria.

The magazine "Lancet" argues that the bank podtasoval data to its projects to combat malaria looked successful, but it has not fulfilled promises to invest 300-500 million dollars in Africa.

According to the magazine, the World Bank financed outdated drugs, despite the objections of experts.

The World Bank denied the charges, saying that in the next five years is going to invest in the fight against malaria from 500 million 1 billion dollars.

However, the bank management recognizes that it is very difficult, and sometimes even impossible "to find out exactly how many funds to a donor spent on specific activities.

Blaming the bank made 13 international experts in the field of health led by Amir Attaranom from the University of Ottawa in Canada. Mainly they relate to the data bank promises in the fight against malaria in Africa and in India.

Indifference

Researchers blamed the World Bank for failure to change the historical indifferent attitude towards the fight against malaria, as well as trying to enlarge its expenditure to finance the fight against the disease in Africa.

The "Lancet" emphasizes the bank promise to Africa 300-500 million dollars to fight malaria.

Then, say the authors, the bank took his words back, because, according to reports, on measures to combat malaria in 2000-2005 worldwide bank planned to allocate only 100-150 million dollars.

In response to the accusation Bank representative Jean-Louis Sarbib said that between the years 2006-2008 to spend on malaria in Africa and Asia 500 million dollars.

The "Lancet" also said that the World Bank podtasoval in profitable for themselves the results of the programme to combat malaria in India.

The authors have data bank, which, the number of deaths from malaria in some parts of India, reportedly declined sharply: in Gujarat by 58%, in Maharashtra, 98% in Rajasthan by 79%.

The authors of the journal began to doubt that such success has been achieved in such a short time, and asked for official statistics national measures against malaria Indian authorities.

Chloroquine for India

Researchers also claim that "secrecy, which the bank covers its activities, and technical errors have become dangerous combination when it comes to drugs against malaria."

"Our investigation suggests that the Bank has donated funds to potrtil useless drugs," says Amir Attaran

Bank accused of being supplied to India Anti drug chloroquine in the amount of 1.8 million dollars, while the drug is not widespread in India to the type of malaria, as reflected in the recommendations of the World Health Organization.

However, the bank said that chloroquine was intended only for those areas where it is effective and delivered to the country and other drugs.

Dr. Attaran and his colleagues called on the World Bank to allocate 1 billion dollars to be spent on anti-malaria worldwide, a separate structure, noting that the Bank's role should be only for money.

However, the bank responded as follows: "The President of the World Bank Paul Wolfowitz fully supported the desire of the bank to participate in the fight against malaria and to achieve significant results."

The "Lancet" that malaria is the cause of 10% of diseases in Africa, resulting in an annual loss of $ 12 billion dollars.

It was found that the number of deaths from malaria in the same period (2002-2003 d.) in the three states increased.

However, according to the World Bank, the "Lancet" used "combined statistics at the state level, which did not show the full picture."

Drugs for shop-dependence

Doctors have set a new medicine to those suffering from addiction to waste money on buying "shop-dependence". Medicines originally intended for suffering depression.

Shop like many. However, according to doctors, one in five of us Later became of the lessons that need treatment.

More and more people, especially women, advantages in debt. Now all the easier to take the money borrowed. We are increasingly following the fashion, and away by the growing influence of advertising.

Doctors in the United States began to set drug ultram online pharmacys Cipramil those who can not stay and continue to make purchases, despite its growing debt.

Cipramil - antidepressant, from the same group of drugs that Prozac and popular.

A study walmart pharmacy conducted at Stanford University Medical School in the United States, over 21 women found that Cipramil well help from "shop-dependence".

Dr. Robert Lefever, director of the centre Promis in the county of Kent in southeast England. Center be specialize to help people with all sorts of mania.

He believes that addiction to waste money on buying a canadian pharmacy problem no less serious than alcohol or recreational gambling, and could lead to at least a serious problem, particularly to the huge debt.

Medicines for HIV pregnant

A study of nearly two thousand women in West Africa, has confirmed that the medicines human immunodeficiency virus help prevent the transmission of the virus from pregnant woman her child.

However, the researchers also found that in the future, many children are infected in the process of breastfeeding.

Scientists have concluded that HIV-positive mothers should continue treatment in the first months of life to their children.

A survey published two days after the South African highest court ruled that the government must provide pregnant women with HIV drugs.

An estimated one in nine South African resident infected with HIV.
Pharmacy news. BBS

Fake drugs kill

Scientists beat alarm and called for urgent action at the international level to end the sale of counterfeit medicines.

In a scientific journal published an article, which highlights the serious risks because of forgery issued for these medicines. The most widespread problem was in developing countries.
Article in the British medical journal entitled "fake drugs, guns kill." The team of scientists from various countries, which is led by Paul Newman of the University of Oxford, blames criminal organizations in the death of many people who counterfeit medicines.

Among the examples cited by eye drops are false, "vaccine" against meningitis, facing an easy tap water and "contraception", made from wheat flour.

All these "medicines" manufactured in clandestine laboratories.

Five Asian countries, researchers found numerous cases of trafficking in counterfeit drugs.

"A third of the samples drug against malaria, we have acquired in Southeast Asia were false and did not contain any traces of chemicals that should have been part of medicine," says Neuman.

Lucrative business

The World Health Organization believes that forgery is approximately the 10th of the drugs sold worldwide. Paul Newman and his colleagues propose to the WHO to discuss the issue at the forthcoming conference in September.

According to Lambert Rago, WHO Representative, scientists do not exaggerate the extent of the danger:
"Counterfeit drugs kill people. Here comes the many reports that the vaccine does not contain any therapeutic components, therefore, the vaccination did not occur, "says Rago.

The production of counterfeit medicines has become a lucrative illegal businesses are international in scope. According to Rago, often counterfeits are produced in large numbers in one country and sold in another.

WHO has appealed to various pharmacological Association and customs authorities to join efforts in the fight against trafficking in counterfeit medicines.

Curative properties of herbs under suspicion

American scientists found that the treatment of choice properties in recent medicines made from the resin of Indian plants guggula heavily priukrasheny.

Previously, it was thought that guggul could significantly lower concentrations of cholesterol in the human body. It is known that cholesterol is responsible for many cardiovascular diseases.

However, drugs made by guggula used in India since ancient times, no tests were conducted at a university of Pennsylvania.

Doctors identified 103 volunteers and divided them into three groups. The first group of test given pills containing 1 gram of resin extract guggula, three times a day. In the second dose group was double, and third of patients received sham pills.

Better self-medication

Two months doctors found that in the first and second group of volunteers cholesterol levels did not fall, but increased by 4% and 5% respectively.

Amazing was the fact that the third group, which received a sham drug test (but did not do so), the average cholesterol level decreased by 5%.

In the experiment, and found one additional side effects drugs. Some volunteers during a guggula appeared skin irritation.

Researchers believe that the results of their work once again shows that medicinal herbs and products made from them should undergo more thorough review before come to the store shelves.

"Vitamins and herbal medicines on the basis must be seriously studied as to their safety and effectiveness," says study leader Philip Zapari.

It should be noted that previous tests guggula held in India and the United States pointed to the miraculous properties of plants. In India, was published, which stated that the admission extract guggula 24 weeks reduces cholesterol content in human blood by 12%.

In the United States earlier this year was published, alleging that guggul help people suffering from osteoporosis and relieve pain syndrome.

Heart drugs against HIV

They found that the speed of propagation of the virus in the body of patients slowing. Once patients perestavali medication, the number of agents increased HIV

In the Journal of Experimental Medicine, doctors are saying that drugs designed to combat high cholesterol in the blood may be on the means available to fight the disease. Statiny are millions of people around the world and they are usually cheaper drugs to combat HIV.

Research has been Professor Gustavo Del Real and his colleagues from the Spanish Council for Scientific Research. They say that these drugs are likely to prevent the virus infect healthy cells in the body. The virus can not penetrate through the membrane of healthy cells, has already infected a cell to escape, he can not.

The ensuing experiments on mice showed that statiny can slow the spread of the disease.

Additional studies

Doctors say that the first tests on a small group of patients most promise. "Our results indicate that cardiac drugs from the group can be very suitable antiviral drugs for more accessible AIDS treatment," write Del Real and his colleagues.

They specify that a certain findings required further study. Data show that statiny can stop the spread of the HIV virus sub-1 for the chronically sick. The results suggest the need for studies of new antiviral drugs as these, "says the article.

Recent studies also show that statiny can help in the fight against other diseases, from Alzheimer's to cancer.

The British government has recently liberalized trade in drugs of this type. Now they can be bought at pharmacies without a prescription. Professor Brian Gazzard, director of programs for the Study of HIV in a London hospital of the regional National Health System said that news of interest from Spain.

"Statiny really prevent HIV to enter the cell," he says. - Does this make the conclusion that they may become drug against HIV / AIDS, yet unclear. But these very interesting. "

Brazil to rise in arms for pharmacists

Brazilian Health Minister Humberto Costa said that the cost of drugs "Kaletra" is so high that is the risk to public health.

The authorities gave the American company Abbott Laboratories, which manufactures the drug, 10 days to either reduce prices or allow Brazil to make cheap version.

Representatives of Abbott Laboratories said that if Brazil would fulfil its threat, in the long run, the loser will remain patient.

According to Humberto Costa, if Abbott did not agree with the government, Brazil will produce a copy of the drug in the state laboratory in Rio de Janeiro.

The American company says that, and so sells "Kaletru in Brazil them at a loss, but said that" is ready to cooperate with the government in finding a mutually beneficial agreement. "

According to the Ministry of Health of Brazil, a country with 183 millionth 600,000 people have HIV or AIDS.

Brazilian authorities deserve praise of the international community for having distributed free of charge to all in need of antiretroviral drugs.

According to Brazilian law, the government has the right to violate patents on the production of drugs, if it believes that it is the interest of the nation.

Eminem's treat for medicinal dependence

Star music in the style of rap Eminem has been hospitalized and undergoing treatment for drug addiction. A musician eventually developed a habit of sleeping medication.

This was declared on Friday his agent for public relations.

A few days ago, the musician announced the cancellation of his European tour. The reason cited "excessive fatigue."

David waited in Europe in September. Artist should hold 10 days in Germany, and then go to Ireland.

This name actor Marshal Bruce Mathers. He recently returned from a joint tour with rappers 50 Cent and Lila John, in his hometown of Detroit.

In July, he denied reports that if he intends to go. Musician said that the agreed only a short break and to producer other artists.

"When I say that do break, which means I do break. There was a time when I will not write his own music, and I will producer of other artists, "says Eminem.

"When I understand that I am going to do next, it will tell this to everyone. And not a single reporter, sochinivshemu story about alleged "last original album," added musician.

Reports of care away from the scene appeared after Pruf, another participant in the group D-12, told a Detroit publication that Eminem will make a statement in September, immediately after the end of a European tour.

Manager David said that no definitive decision on what will Eminem in the near future, no. But added that the latest album features "without a doubt the crowning achievement of this phase of his career."

Taiwan ignores patent for a cure for influenza

The Taiwan authorities say that all the same applied to Roche to copy the drug, but the top priority for them is a healthy population.

In itself, Tamiflu is unable to protect them from avian influenza, but are reported to our correspondents, the drug is seen as the best means of vaccine to combat avian version of the disease.

Since December 2003, bird flu has claimed the lives of at least 60 people in Asia.

Scientists fear that the deadly H5N1 strain of avian influenza and agriculture can take a form that is easily transmitted from human to human, and then may start a pandemic of the disease.

To request copy of Tamiflu by Roche asked several governments in the world.

"Cheap and fast"
Taiwan will produce six kilograms of drugs for its version, which the government says is sufficient to rebuild stocks. The country has already started production of medicines, but so far only in small amounts.

Senior Medical Officer said that Taiwan has demonstrated enough goodwill in the negotiations with Roche, and expressed the hope that the Swiss company would allow his country to copy drugs.

"The negotiations with Roche we did all we could," said Xu Ihzhen Reuters.

Reportedly, his own version of the drug on 99% repeats original recipe Roche. According to the officials, they can quickly and cheaper than a Swiss company to produce its own version of the drug.

Despite the fact that Taiwan has not been a major outbreak of avian flu in neighbouring countries, the virus still killed thousands of birds, and many people have been in contact with diseased chickens.

Avian influenza has already traveled to Europe. The last recorded cases were registered in Britain : in quarantine died brought from Suriname Parrot. However, that which was brought from Suriname in South America bird was in quarantine, Britain's status as a country where there is still no avian flu has not changed.

Meanwhile, Russian authorities announced a new outbreak of avian flu in the Chelyabinsk region. In the village of Sunaly more than 30 birds died from the disease, but it is still unclear whether hit by the H5N1 strain of the virus. In the village, which is home to 89 people, announced quarantine, vaccination will begin on Monday residents. Since infected birds contacted seven people, including one child. Now people feel good. According to the Emergency Situations Ministry, the infection has been recorded migrating birds.

The CART allocates $2,15 billion for a tuberculosis

The CART especially disturbs a tuberculosis with wide medicinal stability which practically is not treated by antibiotics. Since 2006 it is fixed in 37 countries of the world. In opinion of experts, every year appears up to 30 thousand cases of this dangerous form of an infection.

With usual forms of a tuberculosis every year in the world fall ill 8,8 million person.

Besides every year in the world 450 thousand person catch a tuberculosis with wide medicinal stability from which the basic means of first aid do not help at illness.

As experts believe, medicinal steady forms of a tuberculosis can supersede usual. Therefore experts also plan to begin with them struggle - the CART has allocated 2,15 billion dollars for complex programs of treatment, diagnostic laboratories and development of new vaccines and medicines.

" If to allow medicinal stability to develop and uncontrolledly to extend, we shall appear before threat of replacement of the tuberculosis, giving in to medicamentous treatment, exclusively medicinal a steady tuberculosis. It will reject us back, during an epoch up to the invention of antibiotics, in days of when was considered, that unique methods of treatment are sanatoria, the sun and fresh air, and that without hope for healing ", - the coordinator of the plan " has told To stop a tuberculosis " Floor Nann.

Practically incurable tuberculosis with wide medicinal stability for the first time has been revealed in Southern Africa in March, 2006. From 54 patients in whom it has been found out, in 25 days have died 53.

According to the CART, for March, 2005 in Russia it has been fixed 127 thousand new cases of a tuberculosis in its all forms and 28 thousand death.

Thus up to 30 % of cases, according to the CART, remain not revealed.

New medicine for struggle against a malaria

The international group of scientists has declared successful test for monkeys of a new medicine for struggle against a malaria.

Physicians from France, the Netherlands and speak Colombia, that the preparation under name G-25 operates differently, than existing antimalarial means. It quickly kills transferable mosquitoes parasites who amaze erythrocytes.

Tests have shown, that malarial parasites do not develop immunity to new means, and it solves a problem of many medicines existing now.

The malaria transferred through stings of mosquitoes, amazes annually hundred millions people, basically in Africa and Southeast Asia.

While the basic lack of a new preparation is that it can be applied only in the form of injections, but scientists hope, that within two years they can develop the form of a medicine in the form of tablets.
BBC news.

Medicine against illness Parkinson

The British doctors with greater enthusiasm have apprehended preliminary results of experiments on introduction of a new medicine in the damaged areas of a brain of the people, suffering illness Parkinson.
As they said, the new preparation which has received name GDNF, has considerably improved a condition of five patients. One of them again has found ability to feel smells and to laugh.

Results, according to doctors of clinic Frenchay where experiments were spent, have been received more quickly, than it was expected. At the same time they warn, that more large-scale researches are required, and before reception of a high-grade medicine against illness Parkinson will pass as early as years.
http://news.bbc.co.uk

Scientists have found in the sea a medicine against a cancer

It appears, the microbe living in medusoid essence Lissoclinum patella, makes the substance, capable to struggle with fatal disease.

Moreover, researchers approve, that for manufacture of this key making new medicine it will not be necessary to kill in a plenty of sea inhabitants.

The project is spent under aegis of university of state of Utah, the USA, and National fund of a science.

Unique properties belong to microbes under name Prochloron. These microbes make two substances - patellamid A and C which attribute in turn anticancer properties.

" Coral reeves and other sea environments are similar to tropical woods - they are full of substances which bear in itself potential medical properties ", - speaks Erit Shmit, working above the project.

" Unfortunately, reproduction of such substances - hard-hitting a problem. We have solved it by definition of the specific gene responsible for synthesis of these substances, and its introduction in laboratory bacteria ", - explains Shmit.

To the same conclusions about unique properties Prochloron send also scientists from university in Aberdeen together with colleagues from institute of the sea in Australia.

" It is a step forward on a way to a simple and effective method of use of a combination of substance and microbiological technologies for manufacture " medicines from a bottom sea " which in turn does not threaten with destruction of huge quantity of sea organisms ", - Mettju Fletcher from University of the Wales speaks.

Brazil has settled the conflict to pharmacists

Authorities of Brazil not begin to break the patent for a medicine against AIDS after the American pharmaceutical company has agreed to lower cost of the medicine within the nearest six years.

The Brazilian government and company Abbott Laboratories send to the agreement later 10 days of the intense negotiations.

In the past Brazil declared, that will begin release of cheaper version of a preparation "Kaletra", that put strong pressure upon pharmacists so that those have reduced of the price.

On conditions of the agreement, Brazil will get access to the "know-how" of a medicine and will save 250 million dollars the nearest six years.

Now Brazil annually pays companies Abbott Laboratories 107 million dollars for distribution "Kaletra".

In the application of the pharmaceutical company it is spoken, that cost "Kaletra" in Brazil - the lowest in the world outside Africa. Representatives Abbott Laboratories approved, that if the government of Brazil will break the patent legislation the pharmaceutical companies worldwide cannot invest greater means in development of new preparations.

In the past of authority of Brazil already concluded more favourable to the country contracts with other companies after threatened to ignore patents for manufacture of medicines against acquired immunodeficiency syndrome (AIDS).

"Kaletra" is one of the most widespread antiviral the preparations necessary for treatment of a HIV.

For dispute between Brazil and Abbott Laboratories will end with what, steadfastly watched in developing countries where live about 36 million carriers of a human immunodeficiency virus.

By estimations of Ministry of Health of Brazil, in the country with the 183-million population of 600 thousand have a HIV or are sick of AIDS.

As the correspondent BBS Steve Kingston marks from the Dignity the Valve, the decision of the government will be given a hostile reception by active workers of struggle against a HIV.

They actively supported that Brazil has broken the patent on "Kaletra", including, that, by rules, the country has such right. They spoke, that in this case the prices on antiviral medicines all over the world will go downwards.
----------------------------
Wish to have a body of the dream? Practical advice from the trainer will help the beginner!

In the USA the license for a new medicine from AIDS is given out

Management under the control over products and medicines of the USA has licensed for manufacture and sale of a new medicine for a HIV.

It represents a pill containing three medicinal preparations; to accept it it is necessary once a day.

The medicine has been created in common by companies Bristol-Myers-Squibb and Gilead Sciences and refers to Atripla.

It is calculated on those patients it is necessary for them to accept some preparations simultaneously.

It is expected, that the license for distribution Atripla in the Europe will be given out in following to year.

The pill includes a combination of the most widespread preparations which use a AIDS -infected. It became possible owing to cooperation between two companies which make them.

Now patients should accept every day less pills, than several years ago. For them it is very important to adhere to a precise mode of acceptance of medicines, and the new pill just and facilitates this problem.

However, Atripla - a medicine not for all: it will be manages to one person more than in 1000 dollars a month.

New medicine against Alzheimer's.

The British and Swiss scientists have developed a new medicine for treatment of a diabetes and illness Alzheimer's.

The principle of work of a new medicine consists in its influence on the certain protein causing illness Alzheimer's and the most widespread form of a diabetes.

Tests for animals have passed so successfully, that scientists already plan to test a new preparation in public, suffering illness Alzheimer's.

This disease amazing a brain and leading finally dementia, suffer almost forty millions person all over the world.

In searches of a new effective preparation of scientists it was necessary to test more than hundred thousand chemical components.

New medicine for " a black fever "

The world organization of public health services has informed on the invention of the new medicine, capable to cure " a black fever " which annually carries away lives over 60 thousand person.

According to representatives the CART, new tablets under the name myltephosinus have helped during experimental treatment of 95 % of patients. Besides this medicine is much cheaper than nowadays existing medicines.

Before In total it will act in India where half of all cases of disease is registered by " a black fever " almost. This illness is caused by the parasites amazing a liver and a spleen.

AIDS drug to the dollar

Existing AIDS drugs are usually very expensive. And their cost is the main obstacle to fighting the spread of AIDS in developing countries. But soon there may be antispidovye mixture at reduced prices. That proposal Sipla Indian Pharmaceutical Company Ltd has international charitable organization "Doctors without Borders" on the condition that those distributing the drugs simply free.

Humanitarian proposal from developing countries have constantly complained about the high cost of drugs against AIDS. Typically, the annual supply of medicine for one patient costs several thousand dollars.

The major pharmaceutical companies have agreed to grant patents on the production in the countries of Asia and Africa of cheaper versions of key drugs anti-AIDS. Now his company Sipla Ltd has even more radical initiative. "The commercial value of our products in India in per patient - 1,200 dollars a year, says CEO Hamid Yussuf. Governments, we offer them at the rate of $ 600 per patient. A "Doctors Without Borders" we have done this humanitarian proposal, we are ready to sell our AIDS drugs at a cost of $ 350 per patient, as long as they will distribute them for free. "

MSF agree

Such a proposal could save hundreds of thousands of lives - especially in Africa, where at least 25 million are suffering from human immunodeficiency virus. One of the leaders of "Doctors without Borders" Daniel Berman said that his organization would agree to the terms. "Certainly, we welcome the statement Sipla Ltd, it radically changes the situation. This means that AIDS treatment can be much higher. Two years ago, AIDS treatment was generally in the 12 to 15 thousand dollars per year per patient. Now, these drugs are much more accessible to us, and it also means that we can get a correlative grants from the UK and other European countries ". So MSF hoped that they would soon be able to provide essential drugs to AIDS dozens, or even hundreds of thousands of DEVELOPING countries in Africa and Asia.

Medicines from cancer : scientists happy

American scientists have developed an anti-cancer drug known as 2S4 or Omnitarg, as a result of clinical trials proved to be one of the best known to date drugs of this type.

After receiving his spirits dramatically improved patients late stage lung cancer, prostate, breast, ovary and connective tissue. The drug, a protein which sharply intensifying the immune system of patients. However, officially the effectiveness of new drugs has no one spoke. An only the first stage of testing, which primarily to define how the drug is safe. The los-anzhelesskogo Medical Center Cedars David Agus told the press : "This drug actually worked on the tumor directly, and their size reduced."

First results
A clinical trial of its intravenous drugs to more than 20 patients. The experiment continued for about three weeks. The 42% of patients or reduced the size of tumors by 50%, or stopped growing. The three patients was partial remission, which has continued for several months. The five patients had stabilized. David Agus considers such spectacular results. "All of our patients have taken the drug already in the latter stages of cancer, when no other therapeutic techniques are no longer useful," he said. However, his colleague from the British Cancer Research Fund UK Elaine Vickers calls bit : "The drug was only a small number of patients, and to be confident about the effectiveness of the drugs so far."

New drug for blacks

The Office of the Food and Drug Administration approved the use of U.S. new drug for treating paralysis of the heart. But for the first time authorities have approved the drug only for black people.

The new product "Bidil" designed exclusively for patients of one particular race. A study by the producer of the drug-company Nitromed Incorporated, showed that it reduced the number of deaths from the disease among black patients than doubled, and the need for inpatient treatment fell by 39%. Two previous studies conducted among all racial groups, did not show similar results. The paralysis, heart disease, in which the heart is weakened and unable pumped enough blood. It can cause heart attacks, high blood pressure or infection. Half of patients with the disease die within five years.

Approval "Bidil" for use exclusively in the same race caused some controversy. Some note that the biological reasons that the drugs worked better for the patients of one race does not exist. They believe that everything is done for profit, Nitromed because the company obtained a licence to produce the drug exclusively for blacks, for a period of 15 years. The Office of the Food and Drug Administration insists that the decision was a step toward a more personal medicine, where drugs can be made with the expectation of some people, while others barely act.

"Bidil" is a combination of two older drugs, neither of which was approved for treating paralysis of the heart. Doctors still do not fully understand how the two drugs work together. While the Office has approved the use of "Bidil only among black patients, doctors can prescribe it to anyone who, in the opinion of doctors, medicines can help.

Testing drugs on tobacco

Above drugs against smoking has a number of

In Belgium, began clinical trials of the world's first cure for smoking. The study involved 60 volunteers. The developers will try to prove that the drug prevents ingress TA-NIC nicotine in the brain, and therefore, smoking is not physically accustomed to tobacco.

At this stage of research, scientists want to understand the dose of nicotine is addictive, and what is not. According to the World Health Organization, the world's more than one billion people smoke. Each year about four million people die of cancer, heart disease and other illnesses associated with smoking. In recent years, among those who have decided to quit smoking, enjoyed great popularity nikotinovye special plasters and chewing gum to help quit smoking. The new drugs work quite differently. Nicotine readily enters the brain through blood, which is why smoking is zavysimym of cigarettes.

Immune system

In the body, a new drug makes the immune system to develop antibodies that enter into vzaimodestvie with nicotine molecules. Molecules are increasing in size and can get to the brain. If the study will be successful, the British company Xenova, develops drugs, said that TA-NIC fall-shopped stores within five years. David Oksleyd, executive director of Xenova said : "Many smokers wishing to quit smoking can not even aware of the risks posed by tobacco." Clive Bates, director of Action on Smoking and Health, said : "The medicine can be against smoking is opening one of the most important drugs for cancer, lung and heart disease." "In Britain, about one-third of smokers-4 million people - are trying to quit smoking each year. However, the vast majority are in a few days or weeks and start smoking again, "he said. But Bates stressed that the study in Belgium is only the initial stage of a long process.

Medicines from radiation?

Scientists have developed a drug which they say could protect people from the effects of radiation. The drug under the working title HE2100 was established American company Hollis-Eden Pharmaceuticals. The companies argue that drugs can help most people who were not in the immediate vicinity of the attack with a "dirty bomb".
Preliminary experiments suggest that the drug can stop the bleeding and loss of white blood cells in the body. Specialists Hollis-Eden has experienced only drugs on animals. Test it on humans could not, because the test would have to be radiation. Now the company is planning a larger study. If the results are stable, Hollis-Eden intends to request the United States government for a license to sell the drug. Changes to the rules governing the licensing of American pharmaceutical products, are now allowed to use medicines that have not been large-scale tests on humans. Under the new rules, the drug is tested on primates and small group of volunteers.

The amount of drugs

The United States promised in the next few years for pharmaceutical companies to $ 6 billion for the development of drugs needed to combat the consequences of bioterrorism attacks. According to Bob Marsella of Hollis-Eden, new drugs will cost between 50 and 75 dollars per course, but his store will be a long one. "This will not be a panacea," says Professor Paul Wilkinson of the Center for the Study of Terrorism at the University of St. Andrews United Kingdom. People in the immediate vicinity of the explosion to a dose of radiation that medical intervention will save them. " "But people in the outside radius of the defeat of the medicine might help if further experiments to confirm its effectiveness," he said.
BBC World Service

Men and women need different medicines

Scientists say that the brain of men and women may affect their susceptibility to various diseases, as well as opreledyat their reactions to medicines. Scientists have long noticed that women, for example, more prone to depression and bulimia, while male-to Parkinson's disease. Studies of brain men and women have shown that they are structured differently. Scientists believe that if these two facts together, we can conclude that the future of medicine should be different for men and women. Most drugs are tested on men today. This means that women may not be as effective. Man or woman? We must look at the disease as a male and female Professor Swaab Scientists explained that the formation of the genital organs of the brain and there is a very large difference in time. Genitals are formed in the first half of pregnancy, while the structure of the brain, and in the second part after birth. That is why, scientists believe, there is the possibility of errors when sex is not the same as the "floor" brain. Professor Dick Swaab of the Institute for Brain Research in Amsterdam has long been studied transsexual who claimed that begins in early childhood feel that parents "foreign" body. Swaab said that studying such cases, researchers found that some male female brain structure. "Paul" brain partly depends on the level of hormones : women prevails hormone estrogen, and testosterone for men. The trick hormones? Scientists have found that hormones may influence susceptibility to various diseases. For example, women who suffer from MS, the male hormone testosterone is much lower than that of healthy women. The same dependence observed in cases Parkinson's disease, which is much more common among men than among women. According to Glenda Gillies of Imperial College London, one of the versions is that estrogen may play a protective role in neurons. Some experiments with laboratory rats partially confirm that theory. For example, krysy-samki whose ovaries had been removed, and the sharply reduced level of the female hormone, with the same degree of response to the symptoms of Parkinson's disease, as krysy-samtsy. When they injected enough estrogen, rats regained their defensive reaction to the disease. At the same time, castrate krys-samtsov less experienced symptoms of the disease. But estrogen is not provided wonderful therapeutic actions are, in fact, the only male left in the presence of high female hormone. Alien hormones Gillis believed it might be in the body, there is a programmed response to the "Alien" hormones. This means that drugs can have different effects on male and female organisms. A similar conclusion by many scientists, including Anita Holdcroft, from Imperial College London. Holdcroft said that the level of female hormones in the body, unlike men, constantly changing, and this may depend to drugs. Holdcroft studied brain women during and after pregnancy. It found that during pregnancy women reduced brain, and in the first six months after birth is gradually restoring its size. Holdcroft said that it is not yet clear, nor why this is happening or what the consequences would result.
BBC news